Study of 201 Non-Small Cell Lung Cancer Patients Given Stereotactic Ablative Radiation Therapy Shows Local Control Dependence on Dose Calculation Algorithm

被引:51
作者
Latifi, Kujtim [1 ]
Oliver, Jasmine [1 ,2 ]
Baker, Ryan [3 ]
Dilling, Thomas J. [1 ]
Stevens, Craig W. [1 ]
Kim, Jongphil [4 ]
Yue, Binglin [4 ]
DeMarco, MaryLou [1 ]
Zhang, Geoffrey G. [1 ]
Moros, Eduardo G. [1 ]
Feygelman, Vladimir [1 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, Dept Phys, Tampa, FL 33620 USA
[3] Univ S Florida, Sch Med, Tampa, FL 33620 USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 88卷 / 05期
基金
美国国家科学基金会;
关键词
PROSPECTIVE PHASE-II; BODY RADIOTHERAPY; MONTE-CARLO; PHANTOM; TUMORS; SETUP; SBRT;
D O I
10.1016/j.ijrobp.2013.12.047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Pencil beam (PB) and collapsed cone convolution (CCC) dose calculation algorithms differ significantly when used in the thorax. However, such differences have seldom been previously directly correlated with outcomes of lung stereotactic ablative body radiation (SABR). Methods and Materials: Data for 201 non-small cell lung cancer patients treated with SABR were analyzed retrospectively. All patients were treated with 50 Gy in 5 fractions of 10 Gy each. The radiation prescription mandated that 95% of the planning target volume (PTV) receive the prescribed dose. One hundred sixteen patients were planned with BrainLab treatment planning software (TPS) with the PB algorithm and treated on a Novalis unit. The other 85 were planned on the Pinnacle TPS with the CCC algorithm and treated on a Varian linac. Treatment planning objectives were numerically identical for both groups. The median follow-up times were 24 and 17 months for the PB and CCC groups, respectively. The primary endpoint was local/marginal control of the irradiated lesion. Gray's competing risk method was used to determine the statistical differences in local/marginal control rates between the PB and CCC groups. Results: Twenty-five patients planned with PB and 4 patients planned with the CCC algorithms to the same nominal doses experienced local recurrence. There was a statistically significant difference in recurrence rates between the PB and CCC groups (hazard ratio 3.4 [95% confidence interval: 1.18-9.83], Gray's test P=.019). The differences (Delta) between the 2 algorithms for target coverage were as follows: Delta D99(GITV) = 7.4 Gy, Delta D99(PTV) = 10.4 Gy, Delta V90(GITV) = 13.7%, Delta V90(PTV) = 37.6%, Delta D95(PTV) = 9.8 Gy, and Delta D-ISO = 3.4 Gy. GITV = gross internal tumor volume. Conclusions: Local control in patients receiving who were planned to the same nominal dose with PB and CCC algorithms were statistically significantly different. Possible alternative explanations are described in the report, although they are not thought likely to explain the difference. We conclude that the difference is due to relative dosimetric underdosing of tumors with the PB algorithm. (C) 2014 Elsevier Inc.
引用
收藏
页码:1108 / 1113
页数:6
相关论文
共 33 条
[1]   Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy [J].
Baumann, Pia ;
Nyman, Jan ;
Hoyer, Morten ;
Wennberg, Berit ;
Gagliardi, Giovanna ;
Lax, Ingmar ;
Drugge, Ninni ;
Ekberg, Lars ;
Friesland, Signe ;
Johansson, Karl-Axel ;
Lund, Jo-Asmund ;
Morhed, Elisabeth ;
Nilsson, Kristina ;
Levin, Nina ;
Paludan, Merete ;
Sederholm, Christer ;
Traberg, Anders ;
Wittgren, Lena ;
Lewensohn, Rolf .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3290-3296
[2]   stereotactic body radiation therapy: The report from the AAPM Task Group No. 101 (vol 37, pg 4078, 2010) [J].
Benedict, Stanley H. .
MEDICAL PHYSICS, 2012, 39 (01) :563-563
[3]   A moving target: Image guidance for stereotactic body radiation therapy for early-stage non-small cell lung cancer [J].
Corradetti, Michael N. ;
Mitra, Nandita ;
Millar, Lara P. Bonner ;
Byun, John ;
Wan, Fei ;
Apisarnthanarax, Smith ;
Christodouleas, John ;
Anderson, Nathan ;
Simone, Charles B., II ;
Teo, Boon-Keng ;
Rengan, Ramesh .
PRACTICAL RADIATION ONCOLOGY, 2013, 3 (04) :307-315
[4]   Evaluation of patient setup variability between two different immobilization systems used for SBRT or standard fractionation IGRT in the treatment of lung cancers on a Novalis treatment unit [J].
Dilling, T. J. ;
Chuong, M. ;
Sarangkasiri, S. ;
Walker, L. ;
Noriega, B. ;
Boulware, D. ;
Stevens, C. W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03) :S514-S514
[5]   Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy [J].
Ding, George X. ;
Duggan, Dennis M. ;
Lu, Bo ;
Hallahan, Dennis E. ;
Cmelak, Anthony ;
Malcolm, Arnold ;
Newton, Jared ;
Deeley, Matthew ;
Coffey, Charles W. .
MEDICAL PHYSICS, 2007, 34 (07) :2985-2994
[6]   STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY [J].
Fakiris, Achilles J. ;
McGarry, Ronald C. ;
Yiannoutsos, Constantin T. ;
Papiez, Lech ;
Williams, Mark ;
Henderson, Mark A. ;
Timmerman, Robert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :677-682
[7]   THE LINEAR-QUADRATIC FORMULA AND PROGRESS IN FRACTIONATED RADIOTHERAPY [J].
FOWLER, JF .
BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (740) :679-694
[8]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[9]   DOSE-RESPONSE RELATIONSHIP FOR IMAGE-GUIDED STEREOTACTIC BODY RADIOTHERAPY OF PULMONARY TUMORS: RELEVANCE OF 4D DOSE CALCULATION [J].
Guckenberger, Matthias ;
Wulf, Joern ;
Mueller, Gerd ;
Krieger, Thomas ;
Baier, Kurt ;
Gabor, Manuela ;
Richter, Anne ;
Wilbert, Juergen ;
Flentje, Michael .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01) :47-54
[10]   Stage I Nonsmall Cell Lung Cancer in Patients Aged ≥75 Years Outcomes After Stereotactic Radiotherapy [J].
Haasbeek, Cornelis J. A. ;
Lagerwaard, Frank J. ;
Antonisse, Marilisa E. ;
Slotman, Ben J. ;
Senan, Suresh .
CANCER, 2010, 116 (02) :406-414